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Membranes in cells have deﬁned distributions of lipids in each leaﬂet, controlled by lipid
scramblases and ﬂip/ﬂoppases. However, for some intracellular membranes such as the
endoplasmic reticulum (ER) the scramblases have not been identiﬁed. Members of the
TMEM16 family have either lipid scramblase or chloride channel activity. Although TMEM16K
is widely distributed and associated with the neurological disorder autosomal recessive
spinocerebellar ataxia type 10 (SCAR10), its location in cells, function and structure are
largely uncharacterised. Here we show that TMEM16K is an ER-resident lipid scramblase with
a requirement for short chain lipids and calcium for robust activity. Crystal structures of
TMEM16K show a scramblase fold, with an open lipid transporting groove. Additional cryo-
EM structures reveal extensive conformational changes from the cytoplasmic to the ER side
of the membrane, giving a state with a closed lipid permeation pathway. Molecular dynamics
simulations showed that the open-groove conformation is necessary for scramblase activity.
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Cells and their organelles are enclosed by lipid bilayers andthe lipid composition of either side of these membranes iscontrolled by active transporters (ﬂippases and ﬂoppases)
and passive scramblases, which equilibrate lipids between the
membrane leaﬂets1. Many lipids are synthesised on the cyto-
plasmic side of the endoplasmic reticulum (ER) membrane
which, unlike the plasma membrane (PM), has a symmetrical
lipid distribution, suggesting a role for scramblases in the ER. To
date, speciﬁc ER scramblases have not been identiﬁed and char-
acterised2. The ten members of the TMEM16 scramblase/channel
family of integral membrane proteins (also known as anoctamins
ANO1-10) show a surprising diversity of function, being either
Ca2+-activated chloride channels (TMEM16A and B)3–5 or
Ca2+-activated lipid scramblases with non-selective ion channel
activity (TMEM16C, D, F, G and J)6–9. Although mammals have
ten members in this family, lower eukaryotes generally have fewer
TMEM16s. While some members of the family (TMEM16A, B, F)
reside in the plasma membrane, others, including TMEM16K10
may function in intracellular membranes. TMEM16K is a widely
distributed11, but relatively unstudied member of the TMEM16
family. Truncations and missense variants of TMEM16K
(ANO10) are associated with the autosomal recessive spinocer-
ebellar ataxia SCAR1012,13 (as known as ARCA314–16 or ATX-
ANO1017). SCAR10 causes cerebellar ataxia, with cerebellar
atrophy evident in magnetic resonance imaging scans of brains
and coenzyme Q10 deﬁciency found in muscle biopsy,
ﬁbroblasts and cerebrospinal ﬂuid12,13,18,19. Some patients also
have epilepsy and cognitive impairment14,15. Knockout studies in
Drosophila20 and mice21 have suggested that loss of TMEM16K
homologue function affects spindle formation20, Ca2+ signal-
ling21 and apoptosis20,21.
Structural studies have gone some way towards explaining how
TMEM16 family members function as channels or lipid scram-
blases. The crystal structure of the Nectria haematococca
TMEM16 (nhTMEM16), a fungal lipid scramblase with non-
selective channel activity, revealed a dimer arranged in a bi-lobal
‘butterﬂy’ fold, with each subunit containing a two Ca2+ ion
binding site and ten transmembrane (TM) helices22. Each
monomer has a hydrophilic, membrane-spanning groove that
provides a route for lipid headgroups to move across membranes.
Molecular dynamics (MD) simulations subsequently conﬁrmed
this lipid scrambling mechanism in silico23,24. Structures of the
mouse TMEM16A chloride channel revealed an alternative con-
formation, with two groove-associated transmembrane α-helices
blocking the top of the scramblase groove, forming a closed
pore25–27. In addition, while this paper was under review,
structures of the fungal homologues afTMEM1628 and
nhTMEM1629 and the mouse TMEM16F30 were published,
showing a range of conformations for the fungal homologues, and
closed conﬁrmations of mTMEM16F, involving small movements
of helices near the groove.
In spite of its patho-physiological relevance, TMEM16K
remains a poorly characterised member of the TMEM16 family,
as its cellular localisation, function, regulation and structure are
largely uncharacterised. Here we show that TMEM16K is an ER-
resident lipid scramblase with non-speciﬁc ion channel activity
and a dependence on calcium ions and short chain lipids for
optimum activity. We present structures of TMEM16K solved by
both X-ray crystallography and cryo-electron microscopy,
revealing a classic scramblase fold22, with extensive conforma-
tional changes propagated from the cytoplasmic to the ER face of
the membrane, which lead to opening or closing of the lipid
transporting groove. In particular, these structures reveal the
range of conformations available for scrambling by a mammalian
scramblase. We observe both changes that do not rely on changes
in Ca2+-ion binding and additional, smaller changes that occur
when Ca2+ ions are removed. We use MD simulations to conﬁrm
that in TMEM16K the open groove conformation is necessary for
scramblase activity.
Results
TMEM16K is an ER resident lipid scramblase. The identity of
the membrane environments in which TMEM16K resides has not
been clearly established11,21,31. To investigate this question, we
assessed the subcellular localisation of TMEM16K (initially using
a human TMEM16K construct with a TEV-His10-FLAG tag,
including a tobacco etch virus (TEV) protease cleavage site)
heterologously expressed in adherent monkey kidney ﬁbroblasts
(COS-7) cells. We observed signiﬁcant co-localisation with ER
membranes stained for either the ER-resident chaperone calnexin
(CNX, Fig. 1a, b) or the ER ubiquitin ligase Hrd1 (Supplementary
Fig. 1a, b, Supplementary Table 1). This observation was sup-
ported by staining of endogenous TMEM16K in human bone
osteosarcoma epithelial (U2OS) cells, which also co-localised with
the ER marker KDEL (Fig. 1c, d, Supplementary Table 1).
Together, these data are consistent with TMEM16K primarily
residing in the ER membrane. We also considered the possibility
that a small fraction of TMEM16K might localise to the PM,
where it could function as a Ca2+-dependent ion channel. To test
this, we measured the whole-cell currents in human embryonic
kidney 293T (HEK-293T) cells expressing TMEM16K in the
presence of either 300 nM or 78 μM intracellular free Ca2+
concentration ([Ca2+]i). These [Ca2+]i are sufﬁcient to activate
two TMEM16K homologues, TMEM16A and TMEM16F, a PM
chloride channel3–5,7 and a lipid scramblase with non-selective
ion channel activity6,32, respectively. However, the currents
detected in TMEM16K-transfected cells did not differ from those
seen in mock-transfected cells in either condition (Fig. 1e, f),
suggesting that TMEM16K is not trafﬁcked to PM and/or does
not mediate PM Ca2+-activated currents. These results are in
agreement with reports suggesting that no scramblase activity
was detected at the PM when TMEM16K was expressed in
TMEM16F−/− mouse cells11.
Next, we used a dithionite-based scrambling assay33 (Fig. 2a) to
investigate whether puriﬁed TMEM16K has Ca2+-dependent
scramblase activity, as seen in mammalian TMEM16F6,7,34 and
the fungal afTMEM1633 and nhTMEM1622 homologues. We
found that puriﬁed hTMEM16K, reconstituted into lipid vesicles,
formed from a 7:3 mixture of phosphatidylcholine (PC) and
phosphatidylglycerol (PG), with 16:0–18:1C acyl tails, transports
lipids with a scrambling rate constant of ~0.003 s−1 in 0.5 or
2 mM Ca2+, corresponding to ~100 lipids translocated s−1
(Fig. 2b, d, Supplementary Fig. 3a). Without Ca2+, the rate
constant decreased ~4-fold, indicating that TMEM16K scram-
blase activity is Ca2+ regulated. Other TMEM16 scramblases,
such as afTMEM16, are faster34–36, ~20-fold in 0.5 mM Ca2+ and
~5-fold without Ca2+ (Fig. 2b, d). To test if the slow rate of
scrambling by TMEM16K is dependent on the expression system
used, we compared the activity of TMEM16K puriﬁed from
insect-derived Sf9 cells (Fig. 2d) and from mammalian HEK-293
cells (Supplementary Fig. 3a), and found they have comparable
properties (Fig. 2d). Thus, the slow rates of scrambling in
16:0–18:1 lipids reﬂect an intrinsic property of puriﬁed
TMEM16K.
We recently showed that the activity of the fungal
afTMEM16 scramblase is modulated by membrane thickness,
with thicker membranes inhibiting activity37. Because TMEM16K
resides in the ER membrane, which is thinner than the plasma
membrane38,39, we hypothesised that its scrambling activity
might be enhanced in membranes formed from lipids with
shorter acyl tails40. We found that protein-free liposomes formed
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from 100% short chain 14:0–14:0 PC and PG lipids were not
stable, whereas vesicles formed from a 50–50 mixture of short
14:0–14:0 and long 16:0–18:1 lipids were stable. When
TMEM16K is reconstituted in these mixed membranes, its
scrambling activity dramatically increases (Fig. 2c, d, Supple-
mentary Fig. 3b); in the presence of 0.5 mM Ca2+ the rate
constant of scrambling is ~0.01 s−1, a tenfold increase compared
to that seen in the long chain lipid membranes, and is comparable
to that of afTMEM16 (Fig. 2d). In the absence of Ca2+ the rate
constant of scrambling is ~0.001 s−1, again comparable to that of
afTMEM16. Thus, the activity of TMEM16K increases in thinner
membranes, suggesting that the membrane thickness is a general
modulator of TMEM16 scramblase activity.
Next, we tested whether the TMEM16K scramblase displays a
speciﬁc lipid selectivity using different nitrobenzoxadiazole
(NBD)-labelled probes in the background of the thinner
membranes and found that TMEM16K scrambles phosphatidy-
lethanolamine (PE) and phosphatidylcholine (PC) equally well,
with rate constants of ~0.01 s−1 in the presence of 0.5 mM Ca2+
(Fig. 2e, f, Supplementary Fig. 3c, d). Surprisingly, TMEM16K
scrambles phosphatidylserine (PS) ~3-fold slower, with a rate
constant of ~0.0035 s−1 in the presence of 0.5 mM Ca2+.
Therefore, TMEM16K, unlike its fungal homologues afTMEM16
and nhTMEM1622,33, is at least moderately selective among
different phospholipids. This observation is also consistent with
the relatively low content of PS in the ER compared to the PM.
We used an end-point ion ﬂux assay to test if TMEM16K also
functions as a non-selective ion channel by determining whether
a reconstituted protein dissipates a KCl gradient in the absence of
ionophores8,33. The assay measures the fraction of liposomes that
contain at least one active non-selective channel by determining
the loss of Cl− content from the proteoliposomes in the presence
of a salt gradient (Fig. 2g). We found that TMEM16K functions as
a non-selective channel in mixed chain length liposomes, with
~58% vesicles containing at least one active TMEM16K channel
(Fig. 2h). The activity of TMEM16K is minimally Ca2+-depen-
dent as the fraction of channel-active liposomes in the absence of
Ca2+ ions drops to ~43% (Fig. 2h). This could either reﬂect the
relatively high constitutive activity of TMEM16K in the absence
of Ca2+ seen in the scrambling assay or be due to differential
regulation of the channel and scramblase activities by Ca2+.
Further work will be needed to elucidate this.
In summary, we have shown that TMEM16K is a lipid
scramblase with non-selective ion channel activity that appears to
be mainly resident in the ER membrane. Removal of Ca2+
signiﬁcantly decreases the lipid scramblase activity. This activity
is also sensitive to the lipid chain length of the surrounding
membrane and displays moderate selectivity between different
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Fig. 1 TMEM16K localises predominantly to the ER. a Representative confocal images of COS-7 cells expressing TMEM16K-TEV-His10-FLAG. Cells were
stained for TMEM16K (anti-FLAG: red), the ER resident protein calnexin (CNX: green) and nuclei (DAPI: blue). In the merged panel (lower right), the
degree of TMEM16K and CNX overlap is shown (yellow). Scale bars= 10 μm; magniﬁcation: ×63. b Pearson's correlation and Manders' (M1 and M2)
overlap coefﬁcients determined for TMEM16K (FLAG) and CNX. Mean and s.e.m. are shown, n= 23 cells. c Representative confocal images of U2OS cells
stained using antibodies to endogenous TMEM16K (green), the ER resident protein signature KDEL (red), along with DAPI staining of nuclei and the merge.
Scale bars= 10 µm; magniﬁcation: ×63. d Quantitative analysis of TMEM16K and KDEL colocalisation in U2OS cells (as in b). Mean and s.e.m. are shown,
n= 42. e Whole‐cell current versus voltage relationships for mock-transfected HEK‐293T cells (Mock, n= 15) or cells expressing TMEM16A (n= 13) or
TMEM16K (n= 13) are represented as mean ± s.e.m. [Ca2+]i was 300 nM. f Whole‐cell current versus voltage relationships for mock-transfected HEK‐
293T cells (Mock, n= 12) or cells expressing TMEM16F (n= 17) or TMEM16K (n= 11) are represented as mean ± s.e.m. [Ca2+]i was 78 μM. Source data
are provided as a Source Data ﬁle
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headgroups of the lipid substrate. We propose that TMEM16K
could contribute to the background scramblase activity required
to maintain the even distribution of lipids on either side of the ER
membrane. This activity is particularly important in the ER as
lipids are synthesised on the cytoplasmic face of the membrane,
so constant scramblase activity would be required to maintain the
even distribution.
Crystal structure determination and overall architecture. To
understand the structural basis of lipid scrambling in TMEM16K,
we initially solved its structure by X-ray crystallography. We
obtained preliminary diffraction data from vapour diffusion (VD)
crystals of full-length human TMEM16K, which we improved by
lipidic cubic phase (LCP) crystallisation to obtain 3.4 Å resolution
data. Both structures were solved by molecular replacement
(Methods section, Supplementary Table 2). The structures
were similar (monomer all atom root mean square deviation
(r.m.s.d.)= 0.75 Å), although the crystal packing differs (Sup-
plementary Fig. 4a–c), conﬁrming that the conformation is not
dictated by crystal contacts.
hTMEM16K is a symmetrical homodimer that adopts the
classic TMEM16 butterﬂy fold22,25–27 where each monomer
comprises an N-terminal cytoplasmic domain (NCD) followed
by a ten TM domain (TM1−TM10) and a C-terminal
cytoplasmic α10 (Fig. 3a, b). The ER luminal surface of
hTMEM16K is relatively compact, lacking the long, disulphide-
bonded loops seen in mTMEM16A (Fig. 3a, b, Supplementary
Figs. 2, 4e). The N-terminal, cytoplasmic domain of
hTMEM16K has a four-stranded β sheet (β1, β2, β3 and β8),
with three helices on one side (α1, α3 and α4). These helices are
covered by the β6−β7 hairpin insertion, which is unique to
TMEM16K (Fig. 3c, d, Supplementary Fig. 5a). This β6−β7
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Fig. 2 Characterisation of TMEM16K Ca2+ activated scramblase activity. a Schematic for the dithionite-based phospholipid scramblase activity. b, c
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Ca2+ as red circles (from Sf9-expressed TMEM16K) or blue triangles (from HEK-expressed TMEM16K). All data are reported as the mean ± SD. Source
data are provided as a Source Data ﬁle
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hairpin and the associated loops provide important interactions
between the cytoplasmic domain and the β9−β10 hairpin on
the TM domain (Fig. 3d and Supplementary Fig. 5a). The other
surface of the β-sheet is tightly packed against α8, part of an α-
helical hairpin formed by α7 and α8, extensions of TM6 and
TM7 (Supplementary Fig. 5b). This interaction links the
position of the cytoplasmic domain to the TM helices. In the
region between β3 and α3 the structures of hTMEM16K,
hTMEM16F, mTMEM16A and nhTMEM16 differ signiﬁcantly:
hTMEM16K has a relatively short α3 and a β4–β5 hairpin that
interacts directly with the C-terminal α10A and α10B helices
(Supplementary Fig. 5c–e), linking the position of the
cytoplasmic domain to the dimer interface helices.
The TM domain of TMEM16K is C-terminal to the
cytoplasmic domain and has ten TM α helices with TM3 to
TM7 forming the lipid scramblase ‘groove’ and TM6 to TM8
forming the binding site for two Ca2+ ions, seen in other
TMEM16s (Figs. 3a, b, 4a–e). In hTMEM16K, as in other
TMEM16 scramblases, the groove is lined by a series of charged
and hydrogen bonding sidechains that could interact with lipid
headgroups (Fig. 4b).
The C-terminal region of TMEM16K forms the dimer
interface, consisting of TM10 in the membrane region and its
domain-swapped, cytoplasmic extension, α10 (Fig. 4c, d,
Supplementary Fig. 6a–f). There is a large dimer interface cavity
between TMs 3, 5, 9, 10 and TM10B, which contains several
monoacylglycerol (MAG)7.9 lipids in the LCP structure (Supple-
mentary Fig. 6e). In afTMEM16 we proposed that this cavity
could play a role in deformation of the membrane37, it remains to
be seen if it plays a similar role in TMEM16K.
MD simulations on this TMEM16K conformation show
scrambling. We used MD simulations to investigate how lipids
traverse the TMEM16K groove. Coarse-grained (CG) MD
simulations allow us to sample the longer time scales necessary to
investigate lipid scrambling events. Of note is that of the >3500
membrane proteins analysed for CGMD lipid scrambling, as part
of the MemProtMD database24,41, nhTMEM16 is one of the very
few proteins to display scrambling activity24. CGMD simulations
for hTMEM16K revealed similar lipid translocation events in
both directions through the groove (Fig. 5a–e).
To expand on these observations, we converted a mid-ﬂipping
CG state of TMEM16K in a 1-palmitoyl-2-oleoyl-glycero-3-
phosphocholine (POPC) membrane to an atomistic description.
Here, we also see lipid transport along the groove (Fig. 5f–g
Supplementary Fig. 7a), with the full translocation pathway
sampled. Note that whilst the 2.1 µs of atomistic simulation is
sufﬁcient to observe lipids entering, moving along, and exiting the
groove, no individual lipid fully samples the entire pathway. We
estimate from the data that the atomistic rate is ca. 10-fold slower
than the CG, in line with previous observations about kinetics in
Martini42.
As the scramblase activity was shown to be 20-fold faster when
TMEM16K was placed in liposomes containing short chain lipids,
we ran MD simulation to investigate the effect of changing the
lipids from POPC and 1-palmitoyl-2-oleoyl-glycero-3-phospho-
glycerol (POPG) to 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol
(DMPC)/1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG),
while maintaining the open groove conformation of TMEM16K
in silico. The apparent rate of scrambling increased signiﬁcantly
(Supplementary Fig. 7b) in both directions with the shorter chain
lipids, a result that is consistent with the lipid scramblase assay
results.
Atomistic analysis identiﬁed a large number of residues along
the groove facing sides of TM4 (Tyr360, Ser363, Ala367, Glu371
and Arg375), TM5 (Cys412, Ser415 and Ile419), TM6 (Leu428,
Gln431, Ser432, Leu436, Ser440 and Asn444) and TM7 (Leu503
and Tyr 507) (Fig. 4b) that have a substantial sidechain to lipid
head group interaction occupancy (>30% of simulation time).
These scrambling residues generally retain the hydrophilic proﬁle
of those seen in other TMEM16 scramblases. However, there are
very few highly conserved residues in the groove across the
TMEM16 family, perhaps reﬂecting the general lack of strict lipid
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green. b TMEM16K secondary structure elements, coloured according to (a). c Cytoplasmic domain (blue), α7 and α8 (yellow/purple) and α10 (red) of
TMEM16K viewed from the cytoplasm. d Interactions of the cytoplasmic domain with the TM domain and the C-terminal helices (shown as a molecular
surface coloured as in (a), viewed from the cytoplasm
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speciﬁcity and differences in the roles of the different family
members in various cellular environments. Ser363 is of particular
interest, as in the known scramblases (afTMEM16, nhTMEM16,
TMEM16K and TMEM16F) it is either Ser or Thr, whereas in
TMEM16A it is a Val (Supplementary Fig. 2). Interestingly,
swapping from Val to either Ser or Thr or vice versa switches
TMEM16A to a scramblase and nhTMEM16 to a channel,
suggesting that this residue could be important for scrambling in
TMEM16K9.
The relative lipid distributions in the MD simulations
(as indicated by phosphate and choline occupancy) show only
minimal variance along the length of the scramblase groove over
the time course of the simulation (Fig. 5e, f). This is in contrast to
previously published simulations performed on nhTMEM16,
which identify a more punctuated series of local maxima for
phosphate occupancy along the groove9,23. Taken together the
MD data clearly indicate that the TMEM16K groove serves as a
lipid translocation pathway.
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TMEM16K has a two Ca2+-site and a TM10-α10 Ca2+- site.
Regulation of TMEM16 proteins by cytosolic Ca2+ is thought to
involve the conserved two Ca2+ binding site situated between
TM6, TM7 and TM8. This site is preserved in hTMEM16K
(Fig. 4a–e), with anomalous difference maps conﬁrming the
presence of two Ca2+ ions (Supplementary Fig. 8,a, b) and is
formed from the sidechains of a series of highly conserved resi-
dues (Fig. 4e, Supplementary Fig. 2). Mutation of these residues
reduced Ca2+ binding and stability in mTMEM16K43.
Surprisingly, our anomalous difference electron density maps
revealed an additional Ca2+ ion bound near the dimer interface
between TM2, TM10 and α10, where TM10 emerges from the
membrane (Fig. 4c, d, f, Supplementary Fig. 8,a, c). A fourth Ca2+
ion site on the ER side of the membrane at the dimer interface
(Supplementary Fig. 8d) was seen only in the LCP crystallisation,
not in the VD or other structures, so this site is likely to be the
result of the crystallisation conditions, not a characteristic of the
protein or this conformation. The TM10 and α10 Ca2+ ion
interacts with the sidechains of Glu259 and Asp615 and the
backbone carbonyls of Ala610 and Ile613, terminating the TM10
helix (Fig. 4f). In one case of ataxia associated with compound
heterozygous TMEM16K mutations, one TMEM16K allele has an
Asp615Asn mutation13, which could partially impair Ca2+-bind-
ing at the TM10-α10 site (Fig. 4f). However, initial experiments
suggested that the Asp615Asn mutant did not alter lipid
scrambling compared to WT TMEM16K in the presence of
either saturating or 0 mM Ca2+ (Supplementary Fig. 3e, f).
Therefore, further work is required to characterise the effect of
this mutation. Interestingly, the residues coordinating this site are
conserved in mammalian, but not fungal TMEM16s (Supple-
mentary Fig. 2). Indeed, inspection of the mTMEM16A electron
density maps showed density at this location consistent with a
Ca2+ ion (Supplementary Fig. 8j), while a recent publication
conﬁrmed the presence of a Ca2+ ion at this site in TMEM16F30.
TMEM16K cryo-EM structures reveal a closed groove state. To
understand whether TMEM16K can adopt alternative con-
formations and how changes in Ca2+ concentration affect the
structure, we obtained three electron cryomicroscopy (cryo-EM)
structures for TMEM16K in the presence of (i) 2 mM (‘high’)
Ca2+, (ii) 430 nM (‘low’) Ca2+ and (iii) in the absence of Ca2+ (in
10 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetra-
acetic acid (EGTA), ‘Ca2+-free’). These data sets had resolutions
of 3.5, 4.2 and 5.1 Å respectively (Supplementary Figs. 9–11,
Supplementary Table 3). The ‘low’ Ca2+ concentration sample
was obtained without addition of either Ca2+ or EGTA during
puriﬁcation. As the concentration of Ca2+ in our buffers was
found to be 431.5 ± 73.5 nM: (n= 3, s.e.m. estimate of error), we
refer to this as a 430 nM Ca2+ sample, although the protein itself
has additional bound Ca2+(see Methods section for further
details). All the protein samples used in cryo-EM were puriﬁed in
the detergent undecyl maltoside (UDM) with cholesteryl hemi-
succinate (CHS) added to improve protein stability: the same
lipid detergent combination that was used for the VD crystal-
lisation. The low and high Ca2+ structures are remarkably similar
(mainchain r.m.s.d. of 0.42 Å); therefore below we describe the
higher resolution 2 mM Ca2+ structure, unless otherwise stated.
All three structures showed a dramatic change in conformation
with extensive movements from the cytoplasmic to the ER side of
the membrane, converting the classic scramblase open groove
arrangement described above, to a state where the groove is
closed at the ER end. In the groove region, this conformation
resembles the Ca2+-bound state of the mTMEM16A channel25–27,
and the recently published TMEM16F30, afTMEM1637 and
nhTMEM1629 closed groove structures (Fig. 6f, h, Supplementary
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Fig. 5 CG and atomistic MD simulations of TMEM16K structures reveal
lipid scrambling. a View of CG TMEM16K after ~8 μs simulation. The
protein backbone surface (grey and white) and scrambling lipid
molecules (blue, red and green sticks) are shown, b as panel (a), but
rotated by 90o and showing the pathway of a single lipid. The before and
after poses are shown as green, blue and cyan sticks, with the phosphate
head group particle shown as a gold/grey sphere. The scrambling
pathway is denoted by red-to-green coloured spheres from cytoplasmic
to luminal side. c, d Traces showing quantiﬁcation of CG lipid scrambling,
across the z-axis, with the position of phosphate beads in each
membrane leaﬂet shown in light grey. The traces show c lipids that ﬂip
from cytoplasmic to lumenal leaﬂets, and those that ﬂip in the opposite
direction, d, e Density of lipid headgroups along a plane through the
membrane, as computed over 10 µs of CG simulation. Density is scaled
from blue to green, with a scrambling pathway clearly visible along the
TMEM16K hydrophobic groove. f As panel (e) but of 2.1 µs of atomistic
simulation, and calculating the densities of all non-hydrogen head group
atoms. The densities reveal a similar pattern to the CG data. g Lipids
engaged with the TMEM16K translocation pathway in a 2.1 µs atomistic
simulation, coloured as per panel (a)
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Fig. 12a). Although the Ca2+ concentration is reduced from
100 mM in the X-ray structures to either 2 mM or 430 nM for
the cryo-EM structures, there is clear density for Ca2+ ions at
both the TM6-8 site and the TM10-α10 site (Supplementary
Fig. 8e−h). Therefore, these conformational changes are not
caused by loss of Ca2+ binding at either site.
The change from an open to a closed scramblase groove state is
associated with extensive movements of the cytoplasmic domain
and several transmembrane helices, leading to the ER end of the
TM3−TM4 α-helical hairpin blocking the ER end of the groove
(Fig. 6, Supplementary Fig. 12). Within each TMEM16K
monomer, there are two signiﬁcant independent domain move-
ments, one involving the region from β9 to TM5 and other
involving the cytoplasmic domain44. There is a semi-rigid TM
scaffold sub-domain consisting of TM1-2, TM7-8 and TM9-10,
and the two Ca2+ ions (Fig. 6b). The rest of the structure is
divided into two parts that move separately. The ﬁrst unit,
referred to here as the TM3–5 unit, consists of the β9–β10
hairpin, TM3, TM4 and TM5, as well as the domain-swapped α10
from the other chain. This whole unit rotates by ~17° relative to
the scaffold domain, bringing α10 and the β9–β10 hairpin
towards the front of cytoplasmic domain, as shown by torsional
analysis using DYNDOM44 (Fig. 6b–d, Methods section and
Supplementary Fig. 12, Supplementary Movie 1). This allows
TM3, TM4 and TM5 to move up, with TM3 and TM4 pivoting
around TM5. This causes TM4 to move up to 10 Å at its ER end,
so that it can fold over the groove, blocking the ER end of the
groove (Fig. 6c, e–h). The second unit, consisting of the N-
terminal cytoplasmic domain up to α6 and the α7−α8 helices
(cytoplasmic extensions of TM6 and 7), rotates downwards by 5°
relative to the TM scaffold structure (Supplementary Fig. 12f).
This causes the cytoplasmic domain to move down and away
from the TM helices and the TM3−5 unit.
TM6 lies between the scaffold and the TM3−5 unit, and is
divided into TM6a, which moves ~1 Å with the TM3−5 unit, and
TM6b, which forms part of the two Ca2+-binding site and is
associated with the TM scaffold domain (Supplementary Fig. 12e,
f). TM6 therefore provides a ﬂexible buffer between the scaffold
and the TM3−5 unit, and has an ordered α7 extension which
interacts with α8 and the N-terminal cytoplasmic domain (Fig. 6a,
b, Supplementary Fig. 12e, f).
Unlike other TMEM16s, TMEM16K shows signiﬁcant changes
in the relative orientations of the two monomers that make up the
dimer, when comparing the open and closed groove structures
(Supplementary Fig. 12c). At the dimer interface, although the
TM10 contacts are similar, the α10A−α10B contact in the
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Fig. 6 Cryo-EM structure reveals a closed scramblase conformation of TMEM16K. a Structure of TMEM16K in 430 nM Ca2+ obtained by cryo-EM.
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cytoplasm is lost completely in the closed groove structure, such
that the overall dimer interface area decreases by 30% (from 1760
Å2 to 1236 Å2 comparing open and closed groove structures)
(Supplementary Fig. 6f–i). The relatively small changes seen when
the monomers are compared are signiﬁcantly larger when the
TMEM16K X-ray and cryo-EM dimers are superimposed
(Supplementary Fig. 12c). While the relative alignment of the
TM10 dimer helices is the same in both structures, each of the
other TM elements are offset by ~10° and the NCDs rotate by 10°
compared to their positions in the open groove structure. These
changes in domain orientation could contribute to a distortion of
the membrane plane similar to that seen with afTMEM16 37. The
MD simulations (Supplementary Fig. 7c, d) suggest that there
could be some distortion of the planar membrane structure in the
vicinity of the lipid entry route, although this is not as dramatic as
was observed for afTMEM16 37.
Interestingly, the TM3−5 unit forms one side of the
hydrophobic dimer cavity. The presence of this cavity could
provide space to accommodate movements of the TM3−5 unit,
potentially even allowing greater opening of the groove, as
recently proposed35, to accommodate PEGylated lipids36. The
dimer interface cavities in the TMEM16K structures are ﬁlled
with detergent or lipid density in both open and closed groove
states (Supplementary Figs. 6a−f, 9f−h). There is clear density for
one complete lipid molecule in the 3.5 Å closed groove structure,
lying adjacent to TM3, TM5 and TM9, in the cytoplasmic leaﬂet,
a critical site for movement of the TM3−5 unit. It is conceivable
that the nature of the lipids occupying the dimer cavity could
affect the activity of TMEM16K, through direct interactions with
TM helices, α10 and the NCD.
The closed scramblase groove has three distinct sections: a
hydrophilic vestibule on the ER side of the membrane, a narrow
neck and a cytoplasmic vestibule (Fig. 6f, h). The hydrophobic
neck is lined with residues from TM4−7 (Tyr366, Ala367,
Leu416, Ser415, Thr435, Leu436 and Tyr507), which together
form a physical barrier to lipid movement (Fig. 6f, h).
Unsurprisingly, we did not observe lipid scrambling in CGMD
simulations of TMEM16K in this closed groove conformation
(Supplementary Fig. 12j).
TMEM16F scramblase structures observed to date display a
closed groove regardless of the presence Ca2+ref. 30, raising the
question of whether mammalian TMEM16 scramblases can
undergo an open-closed rearrangement similar to that observed
in the fungal afTMEM16 37 and nhTMEM16 29. Our TMEM16K
structures (Figs. 4, 6) suggest that this is the case, by providing
evidence that in a mammalian TMEM16 scramblase the groove
can undergo an open-closed conformational rearrangement.
Moreover, in the case of TMEM16K, movements of the TM3
−TM5 section are accompanied by extensive changes that extend
from the cytoplasmic to the ER side of the membrane, changes
that were not observed in other TMEM16 structures. These
extensive rearrangements are shown not be dependent on
changes in Ca2+ binding.
TMEM16K conformation in the absence of Ca2+. To investigate
how Ca2+ binding regulates the TMEM16K conformation we
determined the cryo-EM structure of TMEM16K in 10 mM
EGTA to 5.1 Å resolution (Fig. 7, Supplementary Fig. 11). This
structure showed that the groove remains closed at the ER end as
seen in both Ca2+cryo-EM structures. However, the Ca2+
-free structure reveals additional rearrangements at the two
Ca2+-binding site (Fig. 7). The TM6-8 two Ca2+-binding site
expands, with TM6/α7 helices moving up and away from TM7/8
by 2−3 Å, and the C-terminal end of the α7 TM6 extension
becoming disordered (Fig. 7a−d). These movements recapitulate
the changes seen in the other TMEM16 family Ca2+-free struc-
tures37 and most closely resembles the Ca2+-free structures of
nhTMEM16 and mTMEM16F in lipid nanodiscs (Fig. 7e). While
the resolution of the Ca2+-free structure is not sufﬁciently high to
resolve whether calcium ions still occupy these sites, the move-
ment of TM6, which provides three sidechain ligands for the dual
Ca2+ site, would suggest that they are not present. The two
Ca2+-binding site is integral to the scaffold domain and forms
one side of the groove, so it is not surprising that conformational
changes associated with loss of Ca2+ affect scramblase activity.
However, TMEM16K retains basal scramblase activity even in the
absence of Ca2+, suggesting that there is an additional, as yet
unknown, open groove Ca2+-free scramblase conformation
(Fig. 8).
Discussion
In this study, we aimed to investigate the structural and func-
tional properties of TMEM16K, together with its subcellular
localisation, to further our understanding of its role in healthy
and diseased cells. Our structures of TMEM16K have allowed us
to explore some of the conformational changes that occur when
the lipid scramblase groove opens and closes (Fig. 8). These
changes are propagated from the cytoplasmic to the ER face of the
membrane through movements of two rigid bodies, one involving
the α10B, β9−β10 hairpin and the TM3−TM5 unit and the other
involving the cytoplasmic domain and the α7−α8 helices. The
ﬁrst unit rotates and moves up so that TM3−TM4 blocks the
groove, while the second unit moves down, providing space for
the ﬁrst unit to rotate. These changes in TMEM16K conforma-
tion are not caused by changes in Ca2+ binding, as all three
Ca2+-binding sites are occupied in both the 2 mM and 430 nM
Ca2+ structures. Complete removal of Ca2+ leads to further
changes in the vicinity of the Ca2+ binding sites and at the lipid
translocation pathway. In the Ca2+-free conformation the groove
is closed, so lipids will not be translocated. Since TMEM16K
scrambling is reduced, but not completely ablated, in the absence
of Ca2+ it is possible that there is an additional, as yet unob-
served, Ca2+-free conformation with an open groove (Fig. 8). We
hypothesise that both the Ca2+-bound and Ca2+-free states exist
as an equilibrium between open and closed groove conforma-
tions; when Ca2+ is bound the open state is preferred, whereas
when there is no Ca2+ bound, the closed state is favoured. Fur-
ther, our data suggest that one additional factor affecting the
equilibrium between open and closed states is the lipid compo-
sition of the membrane. The structures show changes in the lipid
and detergent densities in the dimer interface cavities, although
higher resolution structures will be needed to deﬁne the details of
the lipid interactions.
Our results show that TMEM16K resides mainly in the ER, and
that it has dual activity as a Ca2+-regulated scramblase and non-
selective ion channel. We found that scramblase activity critically
depends on the nature of the lipids in the membrane and
membrane thickness. The scramblase activity is greatly aug-
mented in the presence of shorter chain lipids, which form
thinner bilayers, reminiscent of the ER membrane (Fig. 2c, d).
Continuous scrambling and/or ﬂip/ﬂoppase activities are needed
in ER membranes to redistribute lipids that are synthesised on its
cytoplasmic face. Our results suggest that the scramblase activity
of TMEM16K, possibly together with TMEM16E11,31 and other
opportunistic GPCR scramblases45–47, could contribute to the
scrambling activity required to maintain the symmetrical lipid
distribution of the ER membrane. In contrast, the PM’s highly
asymmetrical lipid distribution is broken down only under
extreme conditions such as apoptosis so that PM scramblases, like
TMEM16F, may require tight regulation6,7,34. We propose that
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the dependence of TMEM16K on membrane thickness might
provide a failsafe mechanism to prevent this protein from
collapsing the membrane asymmetry should it be localised
to non-ER membranes. The structures of the human TMEM16K
presented here, together with the conformational changes seen
in other TMEM16 scramblases (nhTMEM16 and afTMEM1637),
demonstrate that there is extensive ﬂexibility in TMEM16
structures, allowing them to adopt a range of activation states,
potentially triggered by diverse stimuli such as membrane
thickness, lipid composition, posttranslational modiﬁcation or
cofactor binding.
TMEM16K has been associated with several cellular phenom-
ena, including spindle formation20, Ca2+ signalling21, volume
regulation10 and apoptosis20,21. Our work establishes its role as
an ER scramblase, suggesting that the relationship between these
cellular functions and lipid distributions warrants investigation.
These results provide a structural framework to understand how
compound heterozygous missense mutations found in patients
with SCAR10 ataxia could affect TMEM16K function (Fig. 9).
One mutation, Asp615Asn13, lies in the TM10-α10 Ca2+-binding
site (Fig. 4f), where it forms one of the Ca2+ ion ligands and an
ionic bond with Lys262, linking TM2 to the connection between
TM10 and α10. However, activity assays on this mutant protein
did not show changes in scramblase activity, highlighting the
need to assess the function of mutants as well as wild-type (WT)
proteins to understand the effects of mutations. There are also
four missense mutations that introduce residues with very dif-
ferent sized sidechains into key positions between α helices, likely
disrupting helix packing (Gly229Trp14, Leu510Arg12) (Fig. 9b, c)
or interfering with conformational changes (Phe171Ser14,
Phe337Val14) (Fig. 9d, e). The observation that TMEM16K
truncations and missense variants lead to SCAR10 and our dis-
covery that TMEM16K is an ER scramblase, suggest that the
underlying cause of this ataxia could be associated with incorrect
lipid distributions in ER and other membranes. This hypothesis
provides a new direction for research into the underlying biology
of these ataxias and the development of novel therapies.
Methods
Cell culture for electrophysiology and confocal imaging. TMEM16A (Genbank
NM_178642), TMEM16F (NM_175344) and TMEM16K (NM_018075) inserted
into the pcDNA3.1 vector were used in this study. Human embryonic kidney
293T cells (HEK-293T, ATCC collection: ATCC CRL 1573) were grown in
DMEM-F12 medium (D8437, Sigma) supplemented with 10% fetal calf serum and
0.05 mg/100 ml gentamicin. HEK-293T cells were transfected with 0.6 μg of
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TMEM16A, TMEM16F or TMEM16K and 0.2 μg of CD8 construct using Fugene
HD (Promega, UK) according to the manufacturer’s instructions. Cells were used
~12–24 h after transfection. Transfected cells were visualised using the anti-CD8
antibody-coated beads method48. Mock-transfected cells refer to cells treated with
transfection reagent only. COS-7 (ATCC collection CRL-1651) and U2OS (U2OS
FlpIn/T-Rex cells were a kind gift of M. Gyrd-Hansen, Ludwig Institute,
Oxford49,50) cells used for immunostaining were maintained in DMEM high
glucose media (D6546, Sigma) supplemented with 10% fetal calf serum and
0.05 mg/100 ml gentamicin and grown at 37 ˚C in 5% CO2. For each cell line,
solutions were changed every 3–4 days and cells were split to 1/10 when they
reached 70–80% conﬂuence.
Electrophysiology. TMEM16s currents were measured with the whole-cell con-
ﬁguration of the patch-clamp technique using an Axon 200B ampliﬁer (Molecular
Devices, USA) controlled with GE-pulse software (http://users.ge.ibf.cnr.it/pusch/
programs-mik.htm). Currents were low-pass ﬁltered at 2 kHz and sampled at
10 kHz. Pipettes were prepared from borosilicate glass capillary tubes (Harvard
Apparatus, USA) using a PC-10 pipette puller (Narishige, Japan). Pipette tip dia-
meter yielded a resistance of ~2–3 MΩ in the working solutions. The bath was
grounded through a 3M KCl agar bridge connected to a Ag-AgCl reference
electrode. Experiments were conducted at 20–22 °C. The cell capacitance was
assessed by measuring the area beneath a capacitive transient elicited by a 10 mV
step or via the cell capacity compensation circuit of the ampliﬁer. Current density
was obtained by dividing the current amplitude for the cell capacitance.
The extracellular solution contained: 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2,
10 mM glucose, 10 mM D-mannitol and 10 mM HEPES; pH was adjusted to 7.4
with NaOH. The intracellular solution contained: 130 mM CsCl, 10 mM EGTA,
1 mM MgCl2, 10 mM HEPES and 8 mM CaCl2 to obtain [Ca2+]i of ~300 nM; pH
was adjusted to 7.3 with NaOH. The intracellular solution containing ~78 μM
[Ca2+]i was obtained by replacing EGTA with equimolar H-EDTA and by adding a
total of 9 mM CaCl251.
Immunostaining. Immunoﬂuorescence staining was carried out using the (i) COS-7,
(ii) U2OS, and (iii) HEK-293T cell lines. The HEK-293T and COS-7 cells were
obtained from the ATCC collection (ATCC CRL 1573 and CRL-1651 respectively)
and the U2OS FlpIn/T-Rex cells were a kind gift of M. Gyrd-Hansen, Ludwig
Institute, Oxford49,50. Brieﬂy, cells directly plated and grown on glass coverslips were
washed three times with cold phosphate-buffered saline (PBS) (Gibco, UK) and ﬁxed
in 4% paraformaldehyde in PBS for 20min. After ﬁxation, cells were washed twice
with cold PBS. For staining of the ER, cells were permeabilised with 0.2% (v/v) Triton-
X-100 (Merck, UK) in PBS for 5 min. Following this, cells were washed with cold PBS
and then blocked with 0.2% ﬁsh skin gelatin (FSG) in PBS for 30min at room
temperature. Coverslips were then incubated in PBS containing 0.2% FSG with the
following antibodies: anti-FLAG (Sigma, clone M2, F1804, mouse monoclonal, 1:400)
and anti-calnexin (CNX, Enzo Life Sciences, Adi_Spa-860, rabbit polyclonal, 1:400) or
anti-Hrd1 (Abcam, EP7459, rabbit polyclonal, 1:400) for 1 h at room temperature. For
U2OS cells, the following primary antibodies were used: anti-TMEM16K (Sigma,
HPA051569, rabbit polyclonal, 1:100) or anti-KDEL (Enzo Life Sciences, 10C3, ADI-
SPA-827, mouse monoclonal, 1:200). Coverslips were then washed three times with
PBS and stained with appropriate secondary antibodies: anti-mouse IgG-Alexa 546
(Thermo-Fisher, 1:1000) and anti-rabbit IgG-Alexa 488 (Thermo-Fisher, 1:400) for
1 h at room temperature. Nuclei were stained with 4ʹ,6-diamidino-2-phenylindole
(DAPI, Sigma, D9542) before being mounted onto microscope slides using a drop of
Vectashield mounting medium (Vector Laboratories, USA) and sealed with generic
nail varnish. The microscope slides were stored in the dark at 4 °C until imaged.
Imaging analysis was performed by the LSM510 META confocal laser scanning
system (Zeiss, UK) connected to an inverted AxioVert 200 microscope with a ×63
objective (Zeiss, UK), controlled by Zen 2012 (Blue edition) software (Zeiss, UK).
Co-localisation of TMEM16K with ER-resident proteins was quantitatively
assessed by determining the Manders’ overlap coefﬁcient (MOC) and Pearson’s
correlation coefﬁcient (PCC) using Fiji software with the Coloc2 plugin52,53. Two
different MOCs were obtained (M1 and M2), which quantify the independent
contributions of two selected channels to the pixels of interest. M1 represents the
fraction of TMEM16K in regions containing the ER marker while M2 conveys the
fraction of ER marker in regions of TMEM16K. PCCs were also calculated as a
measure of pixel-by-pixel cross-correlation coefﬁcients. MOC and PCC values
range from 0 (no correlation) to 1 (complete overlap).
Cloning and expression for structural and functional studies. The Homo
sapiens TMEM16K gene, which encodes the TMEM16K/anoctamin-10 protein, was
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provided by the DNASU Plasmid collection (https://dnasu.org/DNASU/Home.do).
Coding DNA for the full-length human TMEM16K sequence (NM_018075), Met1
to Thr660 (Uniprot ID: Q9NW15), was cloned into the baculovirus transfer vector
pFB-CT10HF-LIC (available from The Addgene Nonproﬁt Plasmid Repository) for
expression in Spodoptera frugiperda (Sf9) cells (Thermo-Fisher Scientiﬁc, Cat. No.
11496015) using the primers shown in Supplementary Table 4. The vector adds a
C-terminal TEV-cleavable His10-FLAG tag for puriﬁcation. For mammalian
expression, the same construct was also cloned into the pHTBV1.1-LIC baculovirus
transfer vector (The BacMam vector backbone (pHTBV1.1) was kindly provided
by Professor Frederick Boyce (Massachusetts General Hospital, Cambridge, MA)
and adapted for ligation independent cloning in-house for expression in Expi239F
cells (Thermo-Fisher Scientiﬁc, Cat. No. A14527) which similarly confers a TEV
cleavable C-terminal His10-FLAG tag. In both expression cases, baculoviral DNA,
produced by transformation of DH10Bac with either the TMEM16K-pFB-
CT10HF-LIC or TMEM16K-pHTBV1.1-LIC transfer vectors, were used to trans-
fect Sf9 cells to produce baculovirus particles for transduction. Virus was ampliﬁed
by transducing mid-log Sf9 cells (2 × 106 cells ml−1) grown in Sf900IITM media
with 2% fetal bovine serum. Cells were incubated on an orbital shaker for 65 h at
27 °C in 1 l shaker ﬂasks. Baculovirus were harvested by centrifugation at 900 × g
for 20 min and the virus containing supernatant was used to infect 1 l of mid-log
phase (2 × 106 cells ml−1) cultures of Sf9 cells in Sf−900™ II Serum Free Medium
(Gibco/Thermo-Fisher) in a 3 l ﬂask, which were then grown for 72 h at 27 °C on
an orbital shaker. Cells were harvested by centrifugation at 900 × g for 15 min,
washed with phosphate-buffered saline (PBS), and pelleted again prior to ﬂash
freezing in liquid N2, then stored at −80 °C until needed.
For mammalian (Expi293F) expression, baculovirus were prepared in Sf9 cells as
described for insect cell expression. 1 l of Expi293F cell cultures (2 × 106 cells ml−1)
in Freestyle 293TM Expression Medium (Thermo-Fisher) were infected with high-
titre P3 baculovirus (3% v/v) in the presence of 5 mM sodium butyrate in a 2 l roller
bottle (Bioﬁl). Cells were grown in a humidity-controlled orbital shaker for 48 h at
37 °C with 8% CO2 before being harvested by the same process as for insect cells.
TMEM16K puriﬁcation. Sf9 cell pellets containing heterologously overexpressed
protein destined for crystallographic analysis were resuspended in 30 mll−1 equiv.
original cell culture Buffer A (20 mM HEPES pH 7.5, 200 mM NaCl, 5 % glycerol
v/v, 2 mM tris(2-carboxyethyl)phosphine (TCEP)) and lysed by two passes through
a Emulsiﬂex C5 homogeniser (Avestin). A 10:1 mixture of n-Undecyl-β-D-Mal-
topyranoside (UDM)/cholesteryl hemisuccinate (CHS) was added to the lysate
giving a ﬁnal concentration of 1% (w/v) for UDM and 0.1% for CHS, and incu-
bated at 4 °C for 1 h on a roller. Insoluble material was removed by centrifugation
at 32,000 × g for 1 h at 4 °C. The supernatant was supplemented with imidazole pH
7.5 to a ﬁnal concentration of 5 mM, and then a 50% slurry (v/v) pre-equilibrated
TalonTM resin (1 ml slurry per l original culture volume) was added. The sus-
pension was then incubated at 4 °C on a roller for 1 h. Talon resin was collected by
centrifugation at 900 × g for 15 min and transferred to a gravity column where the
remaining liquid was allowed to ﬂow through. Subsequently, all buffer solutions
were supplemented with 0.045%:0.0045% (w/v) UDM/CHS. The resin was washed
with 25 column volumes of Buffer A with 20 mM imidazole, pH 7.5. TMEM16K
was eluted with Buffer A+ 250 mM imidazole. Peak elutions were then exchanged
into Buffer A using Sephadex PD-10 desalting columns (GE Life Sciences). The
protein’s C-terminal 10xHistidine-FLAG tag was removed by overnight incubation
with 5:1 (w/w) TMEM16K:TEV protease. TEV protease and contaminants were
removed by adding 1.5 ml pre-equilibrated 50% Talon resin and batch binding at
4 °C for 1 h on a rotator. The resin was removed by passing over a gravity column,
with the resulting ﬂow-through containing cleaved TMEM16K. Cleaved
TMEM16K was concentrated to <1ml using a Vivaspin 20 centrifugal concentrator
(GE Life Sciences) and further puriﬁed by size exclusion chromatography on a
Superose 6 size exclusion column in Buffer A.
TMEM16K puriﬁcation for cryo-EM data collection was similar to that used for
crystallisation, except that Buffer A was substituted for Buffer B (20 mM HEPES
pH 7.5, 150 mM NaCl, 2 mM TCEP), with lower salt and with the glycerol
removed, to improve the background on cryo-EM images. Puriﬁcation from
transduced Expi293F cells expressing wild-type or mutant TMEM16K was identical
to the protocol used for puriﬁcation from Sf9 cells.
The concentration of Ca2+ in buffers and protein-containing solutions was
determined using Calcium Green™-1 ﬂuorescent indicator (Thermo-Fisher
Scientiﬁc) according to the manufacturer’s instructions. Ca2+ concentration was
calculated from a standard curve derived from solutions of known Ca2+
concentration prepared using the Calcium Calibration Buffer Kit #1 (Thermo-
Fisher Scientiﬁc) according to the manufacturer’s instructions. The sample
described as 430 nM was puriﬁed without the addition of either Ca2+ or EGTA, so
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the Ca2+ present in the sample was obtained from the cells and the puriﬁcation
buffers. We tested the concentration of Ca2+ in our size exclusion chromatography
buffers and found that it was 430± 73.5 nM (n= 3, s.e.m.), so we refer to this
sample as being in 430 nM Ca2+, although it does of course have additional Ca2+
associated with the protein. We measured the concentration of Ca2+ after
removing the protein from a solution containing 1 mgml−1 protein by using a
concentrator with a molecular weight cut off of 10 kDa. The eluate contained
1020 ± 253 nM Ca2+ (n= 3, s.e.m.). This slightly higher concentration could be
due to a portion of the protein denaturing during the separation process. We also
tested the concentration of Ca2+ directly in protein samples with and without
denaturing the protein with heat. When the protein was denatured the Ca2+
concentration was 37.2 ± 10.7 µM (n= 6, s.e.m.). The protein concentration is
13 µM, so with three Ca2+ ions per monomer, we would expect 39 µM Ca2+, which
is similar to the concentration measured. Interestingly, when TMEM16K was not
denatured, we measured a lower concentration of Ca2+ in the solution (2191 ±
243 nM, n= 3), suggesting that TMEM16K can compete with the dye for Ca2+
ions. Since the dye has a Kd of 190 nM for Ca2+, it is possible that TMEM16K has
an afﬁnity for Ca2+ that is higher than 200 nM. However, to accurately estimate the
afﬁnity for Ca2+ requires further work.
Western blots with the TMEM16K antibody. Samples of both puriﬁed
hTMEM16K and lysates from baculovirus-transduced HEK-293 (Expi239F) cells
were run on SDS-PAGE and transferred onto a polyvinylidene diﬂuoride mem-
brane using a Bio-Rad CriterionTM Blotter apparatus, according to the manu-
facturer’s instructions. The membrane was brieﬂy washed in TBS-T Buffer (20 mM
Tris pH 8.0, 150 mM NaCl, 0.1% (v/v) Tween-20) before being blocked by incu-
bation in TBST+ 10 % (w/v) skim milk powder. The membrane was washed
brieﬂy in TBS-T before being incubated overnight at 4 °C with polyclonal Anti-
ANO10 antibody (Sigma-Aldrich, Cat No: HPA051569), diluted 3000:1 in TBS-T.
The antibody solution was decanted from the membrane, which was then washed
3 × 15min in TBS-T. The membrane was then incubated with a secondary
horseradish peroxidase-conjugated anti-rabbit IgG (Sigma-Aldrich, Cat No:
A6667), diluted 1:2000 in TBS-T. The secondary antibody was decanted and the
membrane washed 3 × 15 min in TBS-T. Blots were developed using the ECL
system (Thermo-Fisher) according to the manufacturer’s instructions and digitally
imaged (Supplementary Fig. 1d).
afTMEM16 expression and puriﬁcation. afTMEM16 was expressed and puriﬁed
as described33. S. cerevisiae carrying pDDGFP2 54 with afTMEM16 were grown in
yeast synthetic drop-out medium supplemented with Uracil (CSM-URA; MP
Biomedicals) and expression was induced with 2% (w/v) galactose at 30° for 22 h.
Cells were collected, snap frozen in liquid nitrogen, lysed by cryomilling (Retsch
model MM400) in liquid nitrogen (3 × 3 min, 25 Hz), and resuspended in buffer A
(150 mM KCl, 10% (w/v) glycerol, 50 mM Tris-HCl, pH8) supplemented with
1 mM EDTA, 5 μg ml−1 leupeptin, 2 μg ml−1 pepstatin, 100 μM phenylmethane
sulphonylﬂuoride and protease inhibitor cocktail tablets (Roche). Protein was
extracted using 1% (w/v) digitonin (EMD biosciences) at 4 °C for 2 h and the lysate
was cleared by centrifugation at 40,000 × g for 45 min. The supernatant was sup-
plemented with 1 mM MgCl2 and 10 mM Imidazole, loaded onto a column of Ni-
NTA agarose resin (Qiagen), washed with buffer A+ 30 mM Imidazole and 0.12%
digitonin, and eluted with buffer A+ 300 mM Imidazole and 0.12% digitonin. The
elution was treated with Tobacco Etch Virus protease overnight to remove the His
tag and then further puriﬁed on a Superdex 200 10/300 GL column equilibrated
with buffer A supplemented with 0.12% digitonin (GE Lifesciences). The afT-
MEM16 protein peak was collected and concentrated using a 50 kDa molecular
weight cut-off concentrator (Amicon Ultra, Millipore).
Liposome reconstitution and lipid scrambling assay. Liposomes were prepared as
described33 from a 7:3 mixture of POPC and POPG. Lipids in chloroform (Avanti),
including 0.4% w/w tail labelled NBD-PE, were dried under N2, washed with pentane
and resuspended at 20mgml−1 in buffer B (150mM KCl, 50 mM HEPES pH 7.4)
with 35mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS). TMEM16K or afTMEM16 was added at 5 µg proteinmg−1 lipids and
detergent was removed using ﬁve changes of 150mgml−1 Bio-Beads SM-2 (Bio-Rad)
with rotation at 4 °C. Calcium or EGTA were introduced using sonicate, freeze, and
thaw cycles. Liposomes were extruded through a 400 nm membrane and 20 µl were
added to a ﬁnal volume of 2ml of buffer B supplemented with 0.5 or 2mM CaCl2 or
2mM EGTA. The ﬂuorescence intensity of the NBD (excitation-470 nm emission-
530 nm) was monitored over time with mixing in a PTI spectrophotometer and after
100 s sodium dithionite was added at a ﬁnal concentration of 40mM. Data were
collected using the FelixGX 4.1.0 software at a sampling rate of 3 Hz.
Quantiﬁcation of scrambling activity. Quantiﬁcation of the scrambling rate
constants of TMEM16K and afTMEM16 were determined36. The ﬂuorescence time
course was ﬁt to the following equation:
Ftot tð Þ ¼ f0 LPFi ð0Þ þ ð1 LPFi ð0ÞÞeγt
 
þ 1 f0ð Þ
Dðαþ βÞ α λ2 þ γð Þ λ1 þ αþ βð Þe
λ1 t þ λ1β λ2 þ αþ βþ γð Þeλ2 t
 
;
ð1Þ
where Ftot(t) is the total ﬂuorescence at time t, LiPF is the fraction of NBD-labelled
lipids in the inner leaﬂet of protein-free liposomes, γ= γʹ[D] where γʹ is the
second-order rate constant of dithionite reduction, [D] is the dithionite con-
centration, f0 is the fraction of protein-free liposomes in the sample, α and β are the
forward and reverse scrambling rate constants and
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The free parameters of the ﬁt are f0 and α while LiPF and γ are experimentally
determined from experiments on protein-free liposomes. In protein-free vesicles a
very slow ﬂuorescence decay is visible likely reﬂecting a slow leakage of dithionite into
the vesicles or the spontaneous ﬂipping of the NBD-labelled lipids. A linear ﬁt used to
estimate the rate of this process was estimated to be L= (5.4 ± 1.6) × 10–5 s−1 (n >
160)35. For TMEM16K, the leak is >2 orders of magnitude smaller than the rate
constant of protein-mediated scrambling and therefore was considered negligible. All
conditions were tested side by side with a control preparation of afTMEM16 in
standard conditions.
Flux assay. Cl− ﬂux assay was conducted as described below8. Liposomes were
equilibrated in external buffer with low KCl (1 mM KCl, 300 mM Na-glutamate,
50 mM HEPES, pH 7.4) by spinning through a Sephadex G50 column (Sigma-
Aldrich) pre-equilibrated in external buffer. To complete the experiment, 0.2 ml of
the ﬂow through from the G50 column was added to1.8 ml of external solution and
the total Cl− content of the liposomes was measured using an Ag:AgCl electrode
after disruption of the vesicle by addition of 40 μl of 1.5 M n-octyl-β-D-glucopyr-
anoside (Anatrace). The fraction of liposomes containing at least one active afT-
MEM16 or TMEM16K ion channel, A, was quantiﬁed as follows:
A ¼ 100 ´ 1 ΔCl
ΔClPF
 
; ð4Þ
where ΔCl is the change in [Cl−] recorded upon detergent addition in protein-
containing vesicles and ΔClPF is the Cl− content of protein-free liposomes prepared
in the same lipid composition on the same day.
Statistical analyses. Unless otherwise speciﬁed, all values are the mean ± s.e.m.
and results are expressed as mean ± s.e.m. of n (number of experiments). Statistical
signiﬁcance was determined with two‐tailed unpaired t test or one‐way ANOVA
with Bonferroni's post hoc test, as appropriate. For all statistical tests, P values
<0.05 were considered signiﬁcant. SPSS (version 22; SPSS Inc., Chicago, IL, USA)
or Excel (2013 Edition, Microsoft, Redmond, WA, USA) were used for statistical
analysis.
For scramblase assays, rate constant values reported are the average of 6–9
individual ﬂuorescence traces from three independent reconstitutions of
TMEM16K and afTMEM16. For ﬂux experiments, data points of A (% active
liposomes) were averaged and points outside the 99% conﬁdence interval were
removed. The reported values are the averages of the remaining data points. This
was necessary due to the variability in the recovery efﬁciency of liposomes. The
scrambling rate constants and the % active liposomes are reported as mean ± st.dev.
Crystallisation and X-ray data collection. Puriﬁed TMEM16K was concentrated
to 10–30mgml−1 using a Vivaspin 20 centrifugal concentrator with a 100 kDa
molecular weight cut-off. Protein concentration was determined from the A280 using
a Nanodrop spectrophotometer. TMEM16K was crystallised using both sitting drop
VD crystallisation and in meso in LCP. VD crystals were grown in 0.1M HEPES pH
7.0, 0.1M calcium acetate, 22 % (v/v) PEG400, 0.05mM C12E9 at a protein con-
centration of 10 mgml−1. For LCP crystallisation, 30mgml−1 TMEM16K was
combined with 1-(7Z-hexadecenoyl)-rac-glycerol (monoacyl-glycerol 7.9, Avanti
Lipids) in a 1:1.5 ratio to form a lipid cubic phase. A 50 nl bolus of LCP-reconstituted
TMEM16K was dispensed onto a glass LCP plate (Marienfeld, Germany) and
overlaid with 800 nl of crystallisation solution. TMEM16K crystals grew in an LCP in
a mother liquor containing 0.1M MES pH 6.0, 0.1M NaCl, 0.1M CaCl2, 30 % (v/v)
PEG300. For both LCP and VD crystallisation, initial crystals appeared after 1 week
and grew to full size within 3–4 weeks. All X-ray diffraction data were collected on
the I24 microfocus beamline at the Diamond Light Source (Didcot, UK) from single
crystals using a ﬁne phi slicing strategy. Intensities were processed and integrated
using XDS55 and scaled using AIMLESS56.
Structural model building and reﬁnement. The initial data set collected on the
LCP-derived crystals was phased by molecular replacement using PHASER57 with
the nhTMEM16 structure (PDB: 4WIS) as an initial search model. Phase
improvement was performed using phenix.mr.rosetta58. The ﬁnal model was built
using COOT59 and reﬁned using BUSTER60 using all data to 3.2 Å with appro-
priate NCS restraints. The ﬁnal LCP model was subsequently used as a starting
model for molecular replacement to solve the structure of detergent-solubilised
TMEM16K using an anisotropic data set collected from a crystal grown using
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sitting-drop vapour diffusion methods. The anisotropic nature of the VD data set
prevented it being solved using nhTMEM16 (the only high-resolution structure at
the time) as a molecular replacement search model. Processing of the VD data set
was similar to that for the LCP crystals, with additional anisotropy correction
performed using STARANISO61. The model geometry of the VD data set was
improved by using LSSR target restraints to the LCP structure during BUSTER
reﬁnement in addition to TLS and NCS restraints (Supplementary Table 2).
The ﬁnal LCP model encompasses residues Ser14 to Gln639. Several loops were
poorly order and not modelled; residues 57–67 and part of the α7−α8 loop (residues
472–474) were disordered in chain A. The loops connecting either α5 and α6 or TM3
−TM4 were poorly deﬁned in both chains of the dimer and have also not been
modelled. The ﬁnal model also includes three Ca2+ ions per monomer along with an
additional Ca2+ at the N-terminal end of TM10 on the dimer axis. The presence of
Ca2+ ions at these sites was indicated by peaks in both anomalous difference and
PHASER log-likelihood gradient (LLG) maps calculated using a 3.4 Å data set with
high multiplicity collected at a wavelength of 1.65 Å. Two Ca2+ ions in each dimer lie
at the canonical two Ca2+ ion binding site and a third lies at the junction of TM10
and α10. All of these ions have bonds that are less than 2.5 Å to sidechains, suggesting
the ions are not hydrated. The fourth Ca2+ ion identiﬁed in the anomalous difference
maps lies on the dimer twofold axis, binding to the backbone of the ER loop between
TM9 and 10. The >4Å interaction distances suggest that this ion is hydrated and is
likely to be the result of the high (100mM) [Ca2+] used in the crystallisation
conditions (Supplementary Fig. 8d). This fourth ion is only present in the LCP data
set, not in the vapour diffusion structure, so the presence of this ion is not necessary
for the open conformation to be formed. In addition, elongated density within the
dimer interface were interpreted as MAG7.9 lipids.
Cryo-EM grid preparation. Three microlitres aliquots of TMEM16K protein
puriﬁed in UDM/CHS, at a concentration of 5 mgml−1, was either applied to grid
directly (430 nM Ca2+ samples) or supplemented with 2 mM CaCl2 or 10 mM
EGTA, then were applied to glow-discharged holey carbon grids (Quantifoil R 1.2/
1.3 Cu 300 mesh). Grids were blotted at 80–100% humidity for 3–5 s at 5 °C and
plunge-frozen in liquid ethane using a Vitrobot Mark IV (FEI). Ca2+-free
TMEM16K grids were prepared in an identical manner using protein solution
supplemented with 10 mM EGTA.
Cryo-EM data collection. Grid optimisation and preliminary data set collection
was performed using the Tecnai F30 ‘Polara’ transmission electron microscope
(Thermo-Fisher) at Oxford Particle Imaging Centre (OPIC), Division of Structural
Biology, Oxford operated at 300 kV, at liquid nitrogen temperature and equipped
with a K2 Summit direct electron detector (Gatan) mounted behind an energy ﬁlter
(GIF Quantum LS, Gatan). Screening was also performed using a Talos Arctica
operating at 200 kV equipped with a Falcon3 detector (Thermo-Fisher) at the
Central Oxford Structural Microscopy and Imaging Centre (COSMIC) Oxford
University. Cryo-EM data collection was carried out on a Titan Krios at COSMIC,
operating at 300 kV. Data were acquired with EPU software on a K2 Summit
detector (Gatan) mounted behind an energy ﬁlter (GIF Quantum LS, Gatan) and
operated in zero-loss mode (0–20 eV). For the 430 nM Ca2+ and EGTA data sets,
movies (20 frames, 8 s total exposure) were recorded in electron counting mode at
a sampling rate of 0.822 Å per pixel and dose rate of between 6.36 and 7.06 e−Å−2
s−1 (total dose 51–56.5 e−Å−2) with underfocus in the range from 1.0 to 3.0 µm.
Details of all data sets are given in Supplementary Table 3.
Cryo-EM data processing and model building. All initial processing was carried
out in RELION 2.0 62 and 3.0 63. Frames in each movie stack were aligned and
dose-weighted with MotionCor2 64. CTF parameters were estimated using
CTFFIND 4.0 65. Dose-weighted stacks were subjected to semi-automatic particle
picking using Gautomatch (https://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/).
Particles were picked from a subset of micrographs and 2D classiﬁed to produce
class averages. The resultant representative class averages were then used as tem-
plates in Gautomatch for autopicking the full image sets. Particles were subjected to
multiple (5–6) rounds of reference-free 2D classiﬁcation. An initial model was
generated ab initio in RELION and used as a reference of 3D classiﬁcation with no
symmetry imposed. Particles belonging to the best/highest resolution class(es) were
pooled and taken forward into a second round of 3D classiﬁcation with
C2 symmetry. Finally, particles from the highest resolution class were used for
auto-reﬁnement. The 2 mM and 430 nM data sets were further processed in
RELION 3 63 to take advantage of new particle polishing and CTF reﬁnement
routines. In both cases, two rounds of individual particle CTF reﬁnement inter-
spersed with a single step of Bayesian polishing and 3D auto-reﬁnement produced
the best maps (Supplementary Figs. 9, 10). Further static 3D classiﬁcation where no
image alignment was performed with multiple (10) classes yielded a slightly better
resolved reconstruction for the 2 mM CaCl2 data set. The processing schema for all
the data sets are shown in Supplementary Figs. 9–11. Local resolution estimation
for each ﬁnal reconstruction was performed with RELION66. Post-processing was
carried out in RELION using a mask extended by 12 pixels with an additional 12-
pixel soft edge that excluded the detergent micelle surrounding the protein. Con-
formational homogeneity appears to be well maintained within each data set and at
no stage during 3D classiﬁcation could we detect a subset of particles displaying a
more open groove conformation. For the most part, TM3 and TM4 remain well
resolved within and between different 3D classes indicating a lack of structural
heterogeneity for the region that is responsible for deﬁning the extent of the
scramblase groove.
Model building was carried out manually using the 3.4 Å TMEM16K LCP crystal
structure (PDB: 5OC9) as a template. Brieﬂy, chain A of the crystal structure was
roughly ﬁtted into the 3.5 Å resolution 2mM Ca2+ post-processed cryo-EM map in
UCSF Chimera67. Subsequent model building was carried out in COOT59. The
cytoplasmic domain was rotated into density and then appropriate sub-regions were
ﬁt to the density as rigid bodies. TM helices were ﬁtted as rigid units or segmented
where appropriate. The C-terminal α10 helix was rotated manually into position and
sidechains were ﬁtted using preferred rotamers. The remodelled chain A was
superposed onto chain B and globally ﬁtted to the cryo-EM density to create the
symmetric dimer. Reﬁnement was carried out at 3.5 Å resolution against the post-
processed RELION map (low-pass ﬁltered to 3.47 Å and sharpened with a B-factor of
−112Å2) using phenix.real_space_reﬁne (PHENIX v1.14) using non-crystallographic
symmetry (NCS) constraints, rotamer restraints along with secondary structure
restraints. Missing loop regions, not modelled in the crystal structure, were added and
the calcium coordination was initially deﬁned using phenix.metal-coordination.
Subsequently the calcium coordination at both sites was maintained using distance
restraints derived from the LCP X-ray structure. The ﬁnal model encompasses all
residues from Ser13-Lys641 and three Ca2+ ions per monomer (Supplementary
Table 3). Some of the lipid/detergent-like density around the TM domain at the dimer
interface was modelled by six UDM molecules per monomer and a single
phosphatidylcholine lipid. The precise identity of the lipid bound at the dimer
interface between TM3, 5 and TM10 (of the adjacent monomer) is unknown.
The structure of the 430 nM Ca2+ complex is very similar to the 2 mM Ca2+
structure and only required minor adjustments to the poorly resolved loop regions
between α5−α6 and α7−α8. The density for the detergent and lipid molecules was
present in the map but less convincing at this resolution and so these heterogroups
were removed. The resultant model was reﬁned against the 4.2 Å RELION post-
processed map (sharpened with a B-factor of −176 Å2) using phenix.
real_space_reﬁne. Model geometry was maintained using NCS constraints in
combination with reference model restraints to the 2 mM Ca2+ structure.
The 2 mM Ca2+ structure also served as a template for the low-resolution
Ca2+-free structure. The 2 mM Ca2+ model was initially docked into the map using
Chimera and then reﬁned using phenix.real_space_reﬁne with global minimisation
and morphing using default restraints/constraints and additional secondary
structure restraints. A cryo-EM map, low-pass ﬁltered to 5.1 Å resolution and
sharpened with a B-factor of −150 Å2, was used for all reﬁnement and model
building. The TM1-loop-TM2 region (residues 222–254) and the N-terminal end of
TM10 required additional manual rebuilding/ﬁtting in COOT. The cytoplasmic
α7−α8 region was poorly resolved and truncated between residues 463–474. At this
resolution, there was no obvious density for the amino acid sidechains and the vast
majority were truncated to their cbeta atoms. Only the sidechains of prolines and a
few large hydrophobic residues were retained. In addition, the Ca2+ ions were
removed from the model. The resultant model was further reﬁned with phenix.
real_space_reﬁne using NCS constraints, secondary structure restraints and
reference model restraints to the 3.5 Å 2mM Ca2+ structure (Supplementary
Table 3). All structures/reﬁnement protocols were validated by randomising the
ﬁnal models by applying coordinate shifts of up to 0.3 Å using the noise function in
PDBSET (CCP4). The resultant shifted models were then reﬁned against the
corresponding post-processed half1 maps. Model-to-map Fourier shell correlations
(FSCs) were then calculated with phenix.mtriage using either the ﬁnal reﬁned model
against the full map (FSCsum) or the randomised half map1 reﬁned model against
either the half1 map (FSCwork) or the half2 map (FSCfree) not used in the
validation reﬁnement. FSC plots are shown in Supplementary Figs. 9e–11e.
Structural alignments and analysis. Superposition of the LCP and cryo-EM
structures was carried out in PyMol using a subset of residues corresponding to the
TM helices that maintain their relative orientation within each dimer (as measured
by interhelical angles). Mainchain atoms for residues 208–272 (TM1-TM2),
494–576 (TM7-9) and 589–612 (TM10) were used for the structural superposition.
Overall comparison of the X-ray and cryo-EM structures is further complicated by
the fact that there are also small changes at the dimer interface particularly the
relative orientation of TM10 and α10 which closely interacts with the adjacent
monomer and subtly changes the relative orientation of monomers within each
dimer. Consequently for global comparisons we have carried out the superposition
across both molecules in the dimer (referred to as the dimer superposition) and for
local structural comparisons we have restricted the alignment to the isolated
monomers (monomer superposition) using the above residue range. The ‘dimer
superposition’ was used to prepare Fig. 6c, d, Fig. 8a, d, Supplementary Fig. 12a, c-f
and Supplementary Movie 1. The monomer superposition was used in the pre-
paration of Fig. 8b, c, Supplementary Fig. 12b, g, h, i.
Electrostatic potential surfaces were calculated using the PDB2PQR server and
PyMol with the APBS_2.1 plugin. Structural ﬁgures were generated using PyMol or
UCSF Chimera.
MD simulations. The atomic coordinates of TMEM16K were converted to their
Martini CG representation68,69, and built into membranes following the
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11753-1
14 NATURE COMMUNICATIONS |         (2019) 10:3956 | https://doi.org/10.1038/s41467-019-11753-1 | www.nature.com/naturecommunications
MemProtMD pipeline24. For the data in Fig. 5a−e, membranes were built using a
mixture of 65% POPE, 32% POPC and 3% POPS. To account for the loss of the
Ca2+ ions, the sidechains of the coordinating Asp and Glu residues were modelled
in their neutral form. Simulations were run over multiple µs using a 20 fs time-step.
Simulations were run in the NPT ensemble at 323 K with the V-rescale thermo-
stat70, and 1 bar using semi-isotropic Berendsen pressure coupling71.
Atomistic simulations were run following conversion of 100 ns CGMD
snapshots in a POPC bilayer, where several lipids had been caught mid-scramble.
Conversion were carried out using the CG2AT protocol72 where the original
experimentally resolved protein coordinates, including Ca2+ ions, were substituted
for the post-CG protein coordinates. The Charmm36 forceﬁeld73 was used to
describe the system. Electrostatics were handled using the Particle-Mesh-Ewald
method, and a force-switch modiﬁer was applied to the Van der Waals forces.
Dispersion corrections were turned off. Simulations were run for 100 ns using 2 fs
time steps with Velocity-rescaling temperature coupling at 325 K using a time
constant of 0.1 ps and Parrinello−Rahman semi-isotropic pressure coupling of 1
bar with a time constant of 2 ps, before extension to 2.1 µs, using 4 fs time steps
with virtual-sites on the protein and lipids74.
All simulations were run in Gromacs 5.1.271. Images of proteins were made in
PyMOL75 or VMD76. Graphs were plotted using Python and Matplotlib.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon reasonable request. X-ray crystallography data are deposited in the Protein
Data Bank (PDB) with the following accession codes 5OC9 and 6R65 for the LCP and
vapour diffusion structures, respectively. The cryo-EM density maps and the atomic
coordinates have been deposited in the Electron Microscopy Data Bank (EMDB) and in
the PDB, respectively, under the following accession codes: EMD-4746/PDB 6R7X,
EMD-4747/PDB 6R7Y and EMD-4748/PDB 6R7Z, for 2 mM Ca2+, 430 nM Ca2+ and
Ca2+-free forms respectively. The source data underlying Figs. 1b, d, e and f, Fig. 2b−f,
Fig. 2h, Supplementary Figs. 1b and 3a−f are provided as a Source Data ﬁle.
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